Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGunsynd Regulatory News (GUN)

Share Price Information for Gunsynd (GUN)

Share Price is delayed by 15 minutes
Get Live Data
0.1075    0.005 (4.88%)
Bid:
0.10
Ask:
0.115
Spread: 0.015 (15.00%)
Market Cap: £1.59m
GUN Live PriceLast checked at - London Stock Exchange

Intraday Gunsynd Share Chart

Form 8.3 - Evocutis PLC

14 Dec 2012 15:18

RNS Number : 6083T
Evocutis PLC
14 December 2012
Β 

ο»Ώ

FORM 8.3

Β 

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

Rule 8.3 of the Takeover Code (the "Code")

Β 

1. KEY INFORMATION

Β 

(a) Identity of the person whose positions/dealings are being disclosed:

Richard Farleigh

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

Evocutis PLC

(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:

(e) Date position held/dealing undertaken:

13 December 2012

(f) Has the discloser previously disclosed, or are they today disclosing, under the Code in respect of any other party to this offer?

NO

Β 

Β 

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

Β 

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

Β 

Class of relevant security:

Β 

Ordinary shares of 1p each

Β 

Β 

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

4,726,610

2.70

(2) Derivatives (other than options):

(3) Options and agreements to purchase/sell:

Β 

TOTAL:

4,726,610

2.70

Β 

All interests and all short positions should be disclosed.

Β 

Details of any open derivative or option positions, or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

Β 

(b) Rights to subscribe for new securities (including directors' and other executive options)

Β 

Class of relevant security in relation to which subscription right exists:

Details, including nature of the rights concerned and relevant percentages:

Β 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

Β 

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

Β 

(a) Purchases and sales

Β 

Class of relevant security

Purchase/sale

Β 

Number of securities

Price per unit

Β 

Β 

Β 

(b) Derivatives transactions (other than options)

Β 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

Β 

Β 

Β 

(c) Options transactions in respect of existing securities

Β 

(i) Writing, selling, purchasing or varying

Β 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

Β 

(ii) Exercising

Β 

Class of relevant security

Product description

e.g. call option

Number of securities

Exercise price per unit

Β 

Β 

Β 

(d) Other dealings (including subscribing for new securities)

Β 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

Β 

Β 

Β 

The currency of all prices and other monetary amounts should be stated.

Β 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

Β 

4. OTHER INFORMATION

Β 

(a) Indemnity and other dealing arrangements

Β 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

If there are no such agreements, arrangements or understandings, state "none"

Β 

Β 

Β 

Β 

(b) Agreements, arrangements or understandings relating to options or derivatives

Β 

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

Β 

Β 

Β 

Β 

(c) Attachments

Β 

Is a Supplemental Form 8 (Open Positions) attached?

NO

Β 

Β 

Date of disclosure:

14 December 2012

Contact name:

Dawn Zhu, Barclays Bank

Telephone number:

0203 134 2207

Β 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service and must also be emailed to the Takeover Panel at monitoring@disclosure.org.uk. The Panel's Market Surveillance Unit is available for consultation in relation to the Code's dealing disclosure requirements on +44 (0)20 7638 0129.

Β 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

Β 

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
RETEZLFFLLFFFBQ
Date   Source Headline
3rd Aug 201811:30 amRNSHorse Hill Update
23rd Jul 20181:26 pmRNSSunshine Minerals Update
18th Jul 20182:00 pmRNSHorse Hill Update
27th Jun 20187:00 amRNSHorse Hill Update
14th Jun 201812:30 pmRNSHorse Hill Update
25th May 20187:00 amRNSUpdate on Sunshine Minerals
24th May 20187:00 amRNSUpdate re: FastBase
11th May 201812:41 pmRNSFurther Update on Brazil Tungsten Holdings
29th Mar 20184:35 pmRNSHuman Brands Update
27th Mar 201811:52 amRNSBTHL - Suspension of Operations
23rd Mar 20187:00 amRNSHorse Hill Update
22nd Mar 20184:14 pmRNSHolding(s) in Company
7th Mar 201810:32 amRNSHolding(s) in Company
27th Feb 20184:53 pmRNSFurther Investment in Human Brands
23rd Feb 20182:47 pmRNSHalf-year Report
14th Feb 20188:48 amRNSHolding(s) in Company
12th Feb 20183:41 pmRNSGrant of Options
12th Feb 201810:35 amRNSChange of Registered Office
2nd Feb 20184:03 pmRNSAgreement with FastBase
29th Jan 201812:00 pmRNSHolding(s) in Company
16th Jan 20187:00 amRNSDirectorate Change
19th Dec 20177:00 amRNSHorse Hill Update
18th Dec 20179:00 amRNSInvestment in Human Brands
3rd Nov 20171:23 pmRNSResult of AGM
25th Oct 20179:42 amRNSHolding(s) in Company
18th Oct 20173:45 pmRNSHorse Hill Update
12th Oct 20173:07 pmRNSFinal Results & Notice of AGM
27th Sep 20177:00 amRNSHolding(s) in Company
25th Sep 20172:54 pmRNSInvestment in United Oil & Gas plc
25th Sep 201711:00 amRNSHolding(s) in Company
8th Sep 20177:00 amRNSHorse Hill Update
7th Aug 201711:55 amRNSDirector/PDMR Shareholding
31st Jul 20172:37 pmRNSHolding(s) in Company
28th Jul 20173:37 pmRNSHolding(s) in Company
28th Jul 20173:37 pmRNSHolding(s) in Company
25th Jul 20177:00 amRNSInvestment Update
24th Jul 20172:07 pmRNSHolding(s) in Company
21st Jul 201710:50 amRNSFurther Investment in Oyster and Issue of Equity
5th Jul 20177:00 amRNSHolding(s) in Company
16th Jun 20179:22 amRNSDirectorate Change
5th Jun 20179:19 amRNSHolding(s) in Company
30th May 20174:31 pmRNSSunshine Minerals Research Note
25th May 20179:54 amRNSHolding(s) in Company
11th May 201711:45 amRNSFurther Investment in Oyster Oil and Gas
21st Apr 20177:00 amRNSSunshine Minerals Update and Further Investment
13th Apr 201710:40 amRNSPayment from Integumen plc
4th Apr 20174:17 pmRNSSunshine Minerals Update
4th Apr 20177:00 amRNSHorse Hill Update
3rd Apr 20172:18 pmRNSHolding(s) in Company
30th Mar 20177:00 amRNSAppointment of Director

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.